FOXO3: the longevity gene that shapes lifespan
Forbes - 04-Jan-2024Scientists explore how this key gene affects aging—and how lifestyle may activate its benefits
William Haseltine
President at ACCESS Health International
William A. Haseltine, PhD, has an active career in science, business, and philanthropy. He is known for his pioneering work on cancer, HIV/AIDS, and genomics. He was a professor at Harvard Medical School and Harvard School of Public Health and founder of its Division of Biochemical Pharmacology and Division of Human Retrovirology. He has founded twelve biotechnology companies, including Human Genome Sciences, and is the author of several books.
Visit website: https://accessh.org/our-people/leadership/
See also
ACCESS Health International
Nonprofit think tank and advisory group dedicated to improving access to high quality affordable healthcare
Details last updated 17-Sep-2020
William Haseltine is also referenced in the following:
Targeting Metabesity 2022
10-Oct-2022 to 13-Oct-2022
The Kitalys Institute virtual conference about going beyond treating individual diseases to extending healthy lifespan
Articles written by William Haseltine
New in-ear bioelectronic device could revolutionize brain-computer interface system
Forbes - 09-Aug-2023SpiralE helps advance user-friendly neuroscience applications and regenerative medicine in the future
